Abstract
Aim: To evaluate the clinical effect and to determine the correlation between the initial pathology and postoperative outcome in patients with anterior surface dysfunction treated by amniotic membrane transplantation (AMT).
Material and Methods: 174 AMT of cryopreserved amniotic membrane (AM) performed on 128 patients over a period of two years (01.2014-12.2015). Patients were grouped into 7 cohorts according to the reasons for the AMT - A) corneal recurrent erosions (n = 32), B) postoperative keratitis (n = 7), C) neurotrophic ulcers (n = 14), D) trauma and burns (n = 30), E) bacterial keratitis (n = 10), F) viral keratitis (n = 19) and G) other (n = 16). The groups were assessed for levels of pain (subjective symptom) and hyperemia and size of corneal ulcer (objective signs), and were compared on several stages before and after AMT - day 0, day 8 and day 25.
Results: The AM treatment resulted in significant reduction of the symptoms in all categories. On the 8th day, the observed improvement was bigger than 50% (100% for the pain, 5010% for hyperemia and 6015% corneal ulcer) as at the end of our follow-up hyperemia bettering increased to 8010% and corneal ulcer size decreased with 953% Interestingly, in comparison to day 8, pain levels increased significantly after 25 days of AMT to 1515%.
Conclusion: АМТ is an effective method for managing pathological conditions resulting of damage to the ocular surfaces such as unresponsiveness to common treatment, chronical or recurrent diseases, eye infection and stem cell deficiency. The application of this therapy can have permanent outcome, which results in complete healing of the damaged eye or can serve as a temporal procedure until reconstructive approach is possible. AMT is a treatment of choice in the cases where availability of the corneal tissue is limited.
REFERENCES
Lemp M. A. and Blackman H. J.. Ocular Surface Defense Mechanisms. - Annals of Ophthalmology January 1981;13,no.1:61-63.
De Rotth A. Plastic repair of conjunctival defects with fetal membranes. - Arch. Ophthalmol. 1940; 23:522-522;
Kim J. C. and Tseng S. C.. Transplantation of Preserved Human Amniotic Membrane for Surface Reconstruction in Severely Damaged Rabbit Corneas. - Cornea September 1995;14, no.5:473-84.
Antonietta R., Silini et al. The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine. - Frontiers in Bioengineering and Biotechnology.2015; 3: 162.
Fernandes M. et al. Outcome of Pterygium Surgery: Analysis over 14 Years. - Eye (London, England ),November 2005;19, no.11:1182-90.
Fan Junhua, Wang Meihua, and Zhong Fulu. Improvement of Amniotic Membrane Method for the Treatment of Corneal Perforation. - BioMed Research International 2016.
Gheorghe A. et al. New Clinical Application of Amniotic Membrane Transplant for Ocular Surface Disease. - Journal of Medicine and Life June 2016; 9, no.2:177-79.
Fetterolf Donald E. and Snyder Robert J.. Scientific and Clinical Support for the Use of Dehydrated Amniotic Membrane in Wound Management. - Wounds: A Compendium of Clinical Research and Practice October 2012;24, no.10:299-307.
Sangwan Virender S. et al. Amniotic Membrane Transplantation: A Review of Current Indications in the Management of Ophthalmic Disorders. - Indian Journal of Ophthalmology August 2007;55, no.4:251-60.
Tseng S.C.G. et al. Critical Appraisal of Ex Vivo Expansion of Human Limbal Epithelial Stem Cells. - Current Molecular Medicine December 2010;10, no. 9:841-50.
Baum Jules. Thygeson Lecture. Amniotic Membrane Transplantation: Why Is It Effective?. - Cornea May 2002;21, no.4:339-41.
Lee H. S. and Kim J. C.. Effect of Amniotic Fluid in Corneal Sensitivity and Nerve Regeneration after Excimer Laser Ablation. - Cornea September 1996;15, no.5:517-24.
Ozlem Yalcin Tok et al. Toxic Keratopathy Associated with Abuse of Topical Anesthetics and Amniotic Membrane Transplantation for Treatment. - International Journal of Ophthalmology 2015;8, no. 5: 938-44.
Gillian D. J. Y. Siu, Alvin L. Young, and Lulu L. Cheng. Long-Term Symptomatic Relief of Bullous Keratopathy with Amniotic Membrane Transplant. International Ophthalmology December 2015;35, no. 6.
Shreya Thatte. Amniotic Membrane Transplantation: An Option for Ocular Surface Disorders. - Oman Journal of Ophthalmology May 2011;4, no. 2: 67-72.
Shimmura S. et al. Antiinflammatory Effects of Amniotic Membrane Transplantation in Ocular Surface Disorders, - Cornea May 2001; 20, no. 4:408-13.
Solomon A. et al. Suppression of Interleukin 1alpha and Interleukin 1beta in Human Limbal Epithelial Cells Cultured on the Amniotic Membrane Stromal Matrix. The British Journal of Ophthalmology April 2001; 85, no.4:444-49.
Tseng S. C., D. Q. Li, and X. Ma. Suppression of Transforming Growth Factor-Beta Isoforms, TGF-Beta Receptor Type II, and Myofibroblast Differentiation in Cultured Human Corneal and Limbal Fibroblasts by Amniotic Membrane Matrix,. - Journal of Cellular Physiology June 1999;179, no.3:325-35.
Li Haochuan et al. Immunosuppressive Factors Secreted by Human Amniotic Epithelial Cells. - Investigative Ophthalmology & Visual Science March 2005; 46, no. 3:900-907.
Kamiya K, Wang M, Uchida S, Amano S, Osaka T, Sakuragawa N, et al. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea. - Exp Eye Res 2005; 80:671-679.
Wei Li et al. Amniotic Membrane Induces Apoptosis of Interferon-Gamma Activated Macrophages in Vitro. - Experimental Eye Research February 2006; 82, no. 2:282-92.
He Hua et al. Suppression of Activation and Induction of Apoptosis in RAW264.7 Cells by Amniotic Membrane Extract. - Investigative Ophthalmology & Visual Science October 2008; 49, no. 10:4468-75.
Zhang Suzhen et al. Constitutive Expression of Inter-α-Inhibitor (IαI) Family Proteins and Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) by Human Amniotic Membrane Epithelial and Stromal Cells Supporting Formation of the Heavy Chain-Hyaluronan (HC-HA) Complex. - The Journal of Biological Chemistry April 2012; 287, no. 15:12433-44.
Tseng Scheffer C. G. HC-HA/PTX3 Purified From Amniotic Membrane as Novel Regenerative Matrix: Insight Into Relationship Between Inflammation and Regeneration. - Investigative Ophthalmology & Visual Science April 2016; 57, no. 5: ORSFh1-8.
Chen Szu-Yu et al. HC-HA/PTX3 Purified From Amniotic Membrane Promotes BMP Signaling in Limbal Niche Cells to Maintain Quiescence of Limbal Epithelial Progenitor/Stem Cells. - Stem Cells (Dayton, Ohio) November 2015; 33, no. 11:3341-55.
Huang Yan, Wang,Banwei and Ye Qinying. Clinical study in combining application of mitomycin and amnion transplantation together with pterygium resection. Yan Ke Xue Bao = Eye Science / `Yan Ke Xue Bao` Bian Ji Bu December 2005; 21, no. 4: 110-13.
Wanhong Liang, Rongru Li, and Xingyun Deng. Comparison of the Efficacy of Pterygium Resection Combined with Conjunctival Autograft versus Pterygium Resection Combined with Amniotic Membrane Transplantation. Eye Science June 2012; 27, no. 2: 102-5.
Cheng Anny M. S. et al. Morselized Amniotic Membrane Tissue for Refractory Corneal Epithelial Defects in Cicatricial Ocular Surface Diseases. Translational Vision Science & Technology May 2016; 5, no. 3: 9.
Alio L.Jorge, Arnalich-Montiel Francisco, and Rodriguez E. Alejandra. The Role Of `eye Platelet Rich plasma` (E-PRP) for Wound Healing in Ophthalmology. Current Pharmaceutical Biotechnology June 2012; 13, no. 7: 1257-65.
Morikawa Keisuke et al. Indication and Efficacy of Amniotic Membrane Transplantation Performed under Advanced Medical Healthcare. Nippon Ganka Gakkai Zasshi April 2016; 120, no. 4: 291-95.
Uhlig E. Constantin et al. Long-Term Efficacy of Glycerine-Processed Amniotic Membrane Transplantation in Patients with Corneal Ulcer. Acta Ophthalmologica September 2015; 93, no. 6: e481-487.
Virender S. Sangwan et al. Amniotic Membrane Transplantation: A Review of Current Indications in the Management of Ophthalmic Disorders. Indian Journal of Ophthalmology August 2007;55, no. 4: 251-60.
Prabhasawat P., Tesavibul N., and Komolsuradej W. Single and Multilayer Amniotic Membrane Transplantation for Persistent Corneal Epithelial Defect with and without Stromal Thinning and Perforation. - The British Journal of Ophthalmology December 2001; 85, no. 12:1455-63.
Iakimenko A.Stanislav, Buznyk I. Oleksiy, and Rymgayllo-Jankowska Beata. Amniotic Membrane Transplantation in Treatment of Persistent Corneal Ulceration after Severe Chemical and Thermal Eye Injuries. European Journal of Ophthalmology August 2013; 23, no. 4: 496-503.
Email this article (Login required) 
